GSK3A and lung cancer: Interestingly, our study showed that the GSK-3α knockdown highly suppressed the cell viability of KRAS-WT lung cancer cell lines, H1993 and H1437 cells, compared to KRAS-mutant lung cancer cell lines, H1734 (G13C) and A549 (G12S) cells.